Comparison of immune responses to extracellular domains of mouse and human thyrotropin receptor

Sai A. Patibandla, Ji Lao Fan, Bellur S. Prabhakar, Gattadahalli Seetharamaiah

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The mouse and human thyrotropin receptors show greater than 87% homology in their amino acid sequences. However, glycosylated extracellular domains of mouse (mET-gp) and human (hET-gp) thyrotropin receptors showed differences in their ability to react with patient autoantibodies to thyrotropin receptor (TSHR). To test for potential differences in their immunogenicity, we immunized BALB/c mice with either gel pure non-glycosylated ectodomain of human TSHR (ETSHR II), or hET-gp (hET-gp III), or mET-gp (mET-gp III). Alternatively, mice were primed with gel pure hET-gp or mET-gp and subsequently immunized with insect cells expressing hET-gp (hET-gp II) or mET-gp (mET-gp II) respectively. All groups of mice immunized with TSHR developed high titers of antibodies against the respective immunogens. As shown earlier, sera obtained from mice immunized, with ETSHR showed strong reactivity to peptide 1 (aa 22-41) and weak reactivity to peptides 23 (aa 352-371), 24 (aa 367-386), 25 (aa 382-401), and 26 (aa 397-415). Mice immunized with hET-gp or mET-gp showed comparable titers to peptides 1 and 23 and lower reactivity to other peptides. Mice immunized with hET-gp showed higher TBII reactivity (52.2%) compared to mice immunized with either ETSHR (20.9%) or mET-gp (34.5%). Peptides from the C-terminal region of ETSHR could neutralize the TBII activities of sera from mice immunized with ETSHR or hET- gp but not mET-gp. Compared to corresponding control mice, T4 levels in mET- gp II mice were only marginally higher. These data suggested that outcome of immunization with mouse ETSHR is comparable to that seen after immunization with human ETSHR.

Original languageEnglish (US)
Pages (from-to)205-213
Number of pages9
JournalJournal of Autoimmunity
Volume13
Issue number2
DOIs
StatePublished - Sep 1999
Externally publishedYes

Fingerprint

Thyrotropin Receptors
Peptides
Immunization
Gels
Serum
Autoantibodies
Insects
Amino Acid Sequence

Keywords

  • Autoantibodies
  • Glycosylation
  • Graves' disease
  • Immunogenicity
  • Thyroiditis
  • Thyrotropin receptor

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Comparison of immune responses to extracellular domains of mouse and human thyrotropin receptor. / Patibandla, Sai A.; Fan, Ji Lao; Prabhakar, Bellur S.; Seetharamaiah, Gattadahalli.

In: Journal of Autoimmunity, Vol. 13, No. 2, 09.1999, p. 205-213.

Research output: Contribution to journalArticle

Patibandla, Sai A. ; Fan, Ji Lao ; Prabhakar, Bellur S. ; Seetharamaiah, Gattadahalli. / Comparison of immune responses to extracellular domains of mouse and human thyrotropin receptor. In: Journal of Autoimmunity. 1999 ; Vol. 13, No. 2. pp. 205-213.
@article{4dee61ee58c54631bae6313512c62970,
title = "Comparison of immune responses to extracellular domains of mouse and human thyrotropin receptor",
abstract = "The mouse and human thyrotropin receptors show greater than 87{\%} homology in their amino acid sequences. However, glycosylated extracellular domains of mouse (mET-gp) and human (hET-gp) thyrotropin receptors showed differences in their ability to react with patient autoantibodies to thyrotropin receptor (TSHR). To test for potential differences in their immunogenicity, we immunized BALB/c mice with either gel pure non-glycosylated ectodomain of human TSHR (ETSHR II), or hET-gp (hET-gp III), or mET-gp (mET-gp III). Alternatively, mice were primed with gel pure hET-gp or mET-gp and subsequently immunized with insect cells expressing hET-gp (hET-gp II) or mET-gp (mET-gp II) respectively. All groups of mice immunized with TSHR developed high titers of antibodies against the respective immunogens. As shown earlier, sera obtained from mice immunized, with ETSHR showed strong reactivity to peptide 1 (aa 22-41) and weak reactivity to peptides 23 (aa 352-371), 24 (aa 367-386), 25 (aa 382-401), and 26 (aa 397-415). Mice immunized with hET-gp or mET-gp showed comparable titers to peptides 1 and 23 and lower reactivity to other peptides. Mice immunized with hET-gp showed higher TBII reactivity (52.2{\%}) compared to mice immunized with either ETSHR (20.9{\%}) or mET-gp (34.5{\%}). Peptides from the C-terminal region of ETSHR could neutralize the TBII activities of sera from mice immunized with ETSHR or hET- gp but not mET-gp. Compared to corresponding control mice, T4 levels in mET- gp II mice were only marginally higher. These data suggested that outcome of immunization with mouse ETSHR is comparable to that seen after immunization with human ETSHR.",
keywords = "Autoantibodies, Glycosylation, Graves' disease, Immunogenicity, Thyroiditis, Thyrotropin receptor",
author = "Patibandla, {Sai A.} and Fan, {Ji Lao} and Prabhakar, {Bellur S.} and Gattadahalli Seetharamaiah",
year = "1999",
month = "9",
doi = "10.1006/jaut.1999.0311",
language = "English (US)",
volume = "13",
pages = "205--213",
journal = "Journal of Autoimmunity",
issn = "0896-8411",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Comparison of immune responses to extracellular domains of mouse and human thyrotropin receptor

AU - Patibandla, Sai A.

AU - Fan, Ji Lao

AU - Prabhakar, Bellur S.

AU - Seetharamaiah, Gattadahalli

PY - 1999/9

Y1 - 1999/9

N2 - The mouse and human thyrotropin receptors show greater than 87% homology in their amino acid sequences. However, glycosylated extracellular domains of mouse (mET-gp) and human (hET-gp) thyrotropin receptors showed differences in their ability to react with patient autoantibodies to thyrotropin receptor (TSHR). To test for potential differences in their immunogenicity, we immunized BALB/c mice with either gel pure non-glycosylated ectodomain of human TSHR (ETSHR II), or hET-gp (hET-gp III), or mET-gp (mET-gp III). Alternatively, mice were primed with gel pure hET-gp or mET-gp and subsequently immunized with insect cells expressing hET-gp (hET-gp II) or mET-gp (mET-gp II) respectively. All groups of mice immunized with TSHR developed high titers of antibodies against the respective immunogens. As shown earlier, sera obtained from mice immunized, with ETSHR showed strong reactivity to peptide 1 (aa 22-41) and weak reactivity to peptides 23 (aa 352-371), 24 (aa 367-386), 25 (aa 382-401), and 26 (aa 397-415). Mice immunized with hET-gp or mET-gp showed comparable titers to peptides 1 and 23 and lower reactivity to other peptides. Mice immunized with hET-gp showed higher TBII reactivity (52.2%) compared to mice immunized with either ETSHR (20.9%) or mET-gp (34.5%). Peptides from the C-terminal region of ETSHR could neutralize the TBII activities of sera from mice immunized with ETSHR or hET- gp but not mET-gp. Compared to corresponding control mice, T4 levels in mET- gp II mice were only marginally higher. These data suggested that outcome of immunization with mouse ETSHR is comparable to that seen after immunization with human ETSHR.

AB - The mouse and human thyrotropin receptors show greater than 87% homology in their amino acid sequences. However, glycosylated extracellular domains of mouse (mET-gp) and human (hET-gp) thyrotropin receptors showed differences in their ability to react with patient autoantibodies to thyrotropin receptor (TSHR). To test for potential differences in their immunogenicity, we immunized BALB/c mice with either gel pure non-glycosylated ectodomain of human TSHR (ETSHR II), or hET-gp (hET-gp III), or mET-gp (mET-gp III). Alternatively, mice were primed with gel pure hET-gp or mET-gp and subsequently immunized with insect cells expressing hET-gp (hET-gp II) or mET-gp (mET-gp II) respectively. All groups of mice immunized with TSHR developed high titers of antibodies against the respective immunogens. As shown earlier, sera obtained from mice immunized, with ETSHR showed strong reactivity to peptide 1 (aa 22-41) and weak reactivity to peptides 23 (aa 352-371), 24 (aa 367-386), 25 (aa 382-401), and 26 (aa 397-415). Mice immunized with hET-gp or mET-gp showed comparable titers to peptides 1 and 23 and lower reactivity to other peptides. Mice immunized with hET-gp showed higher TBII reactivity (52.2%) compared to mice immunized with either ETSHR (20.9%) or mET-gp (34.5%). Peptides from the C-terminal region of ETSHR could neutralize the TBII activities of sera from mice immunized with ETSHR or hET- gp but not mET-gp. Compared to corresponding control mice, T4 levels in mET- gp II mice were only marginally higher. These data suggested that outcome of immunization with mouse ETSHR is comparable to that seen after immunization with human ETSHR.

KW - Autoantibodies

KW - Glycosylation

KW - Graves' disease

KW - Immunogenicity

KW - Thyroiditis

KW - Thyrotropin receptor

UR - http://www.scopus.com/inward/record.url?scp=0032831593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032831593&partnerID=8YFLogxK

U2 - 10.1006/jaut.1999.0311

DO - 10.1006/jaut.1999.0311

M3 - Article

C2 - 10479389

AN - SCOPUS:0032831593

VL - 13

SP - 205

EP - 213

JO - Journal of Autoimmunity

JF - Journal of Autoimmunity

SN - 0896-8411

IS - 2

ER -